Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

By T. Mäkikallio, N. Holm, M. Lindsay, M. Spence, A. Erglis, I. Menown, T. Trovik, M. Eskola, H. Romppanen, T. Kellerth and 35 more. The Lancet, 2016

682 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Radiology, Nuclear Medicine and Imaging, Surgery

View Paper: https://www.semanticscholar.org/paper/0f990eaf74f91271c67ed20ab3323b392910e749

Citations in the corpus

• 2018 ESC/EACTS Guidelines on myocardial revascularization. (2019, neutral): “The NOBLE (Nordic-Baltic-British Left Main Revascularization Study) trial compared CABG with PCI using new-generation DES [biolimus-eluting stents (BES)] among 1201 patients with significant LM disease (mean SYNTAX score of 23).(106) At a median follow-up of 3.”